Oncology and Cancer 2022 | Melbourne | Australia | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Cutting-edge Materials Science for Advanced Technologies

- Oncology and Cancer 2022

Welcome Message

We cordially invite you all to the 15th Global summit on Oncology and Cancer and to participate in this global gathering of researchers, oncologists, healthcare professionals, young researchers, students and delegates.

The theme of our conference is ‘Novel research and advancement in the field of Oncology’. It is slated on March 18-19, 2022 in London, UK.

Oncology 2022 provides an opportunity to network with well-known people from around the world and to advance one's knowledge in the field of oncology. Keynote lectures, special sessions, poster presentations, plenary speeches, and more are all part of the conference agenda. All research scholars, academic researchers, doctors, clinical healthcare specialists and young researchers are invited to attend this conference.

It gives you a unique opportunity to network with eminent doctors, professors, researchers, scientists, and CEOs from all over the world, as well as share data with the brightest minds in the fields of Cancer Biology and Oncology, Cell and Gene Therapy, Medical and Radiation Oncology, Metastasis and Drug Resistance, Lung Cancer, Breast Cancer, Clinical Oncology, Chemotherapy, and other related fields.

Why to attend our conference?

We extend you an opportunity to present your work in front of notable experts in the industry.

The opportunity to hear from some of the world's most recognized scientists and lecturers all in one place.

In order to obtain significant CME credits.

Access to the world's leading industries in the subject of oncology.

Your study will be recognized on a global scale.

Meet and greet professionals from all over the globe.

Target Audience:

Oncology Societies
Clinical Researchers
Leading world Doctors
Health Professional
Radiation Therapist
Young researchers
Students and delegates
Drug Manufacturing Companies

Scientific Sessions/Tracks

Sessionon Cancer Biology and Oncology

The body may use celldivision as a conventional means of growth and repair. When there is noneed for more female offspring cells, healthy cells cease proliferating, butcancer cells continue to divide. Cancercells divide uncontrollably, producing solid tumours or infiltrating thebloodstream with aberrant cells. These alterations, as well as the molecularnetworks that control cell proliferation, differentiation, and death, arestudied in cancer biology. Medical specialisation refers to the study ofvarious types of cancer.

Session on Oncology Causes,Diagnosis and Treatment

Changes (mutations) inthe polymer among cells causes cancer. Cancer'ssigns and symptoms vary depending on which region of the body is afflicted. Todiagnose cancer, doctors look at the symptoms and perform a variety ofdifferent tests. Let's look at the current causes and diagnosticprocedures for cancer and tumours throughoutthis session.

Sessionon PreventiveOncology

Between 30 and 50 per cent of all cancer cases are avoidable at the unit level. Interference isthe most effective long-term method for cancermanagement. During this session, we're going to discuss the odds ofpreventing cancer, as well as the stages and tactics involved in doing so!

Sessionon Radiation Oncology

Radiation oncology isan emerging treatment strategy in cancer cure that employs Chemotherapy,Immunotherapy,and HormonalTherapy to treat cancer in an effective manner. This workshop will lookinto an emerging cancer therapy approach.

Sessionon SurgicalOncology

Surgicaloncology is a type of cancer treatment that involves surgery to detect,stage, and treat cancer. The kind, size, location, grade, and stage of the tumour,as well as concerns related to the patient's health, such as age, fitness, andother medical conditions determine whether a patient is a candidate forsurgery.

Sessionon RadiationTherapy

Radiationtherapy to eliminate harmful cells has become a common diagnosis method fora variety of cancers. To cure cancer, it uses X-rays,gammarays, electronbeams, or protons.Adjuvant radiation, palliative radiotherapy,and curativeradiotherapy are the three types of radiotherapy. Early detection, the sizeof the tumour, and the histological makeup of cancer all play a role in itsprognosis. Gamma Knife surgery, Three-Dimensional Conformal Radiation Therapy,Triggered imaging radiosurgery, Brachytherapy, External Beam RadiationTreatment, Total Body Irradiation, Total Skin Irradiation, Stereotactic BodyRadiation Therapy and others are examples of radiation therapy techniques. Thelatest developments in radiation therapy, as well as any novel methods thathave become accessible, can be discussed.

Sessionon CancerChemotherapy

Chemotherapyis a type of cancer treatment that involves the administration of one or moreanti-cancer medications as part of a comprehensive treatment plan. Chemotherapycan also be given with a curative intent, or with the goal of extending life orreducing symptoms. This seminar will look at how to improve treatmenteffectiveness while reducing adverse effects.

Sessionon Melanomaand Carcinoma

Melanomais a dangerous type of skin cancer that starts in cells called melanocytes.Melanoma is far more hazardous than carcinoma because it can quickly spread toother organs if not treated early, whereas carcinomabegins in cells that make up the skin or tissue lining organs like the liver orkidneys.

Sessionon Carcinogenesis & CancerMutagenesis

Carcinogenesisoccurs when normal cells are turned into cancer cells, while mutagenesisoccurs when genetic information is changed in a natural or artificial fashion,and it can result in a variety of disorders, including cancer. As a result,this session looks into the possibility of mutagenesis being reduced.

Sessionon GynaecologicOncology

It is estimated that98,000 women will be diagnosed with gynecologic cancer this year, with only30,000 dying as a result of the illness. Cancers of the femalereproductive system, such as sex gland cancer, female internal reproductiveorgan cancer, canal cancer, cervical cancer, and others, are investigated in Gynecologicmedicine.

Sessionon LungCancer

The overall 5-yearsurvival rate for both limited and extended stage small cell lungcancer is only about 6% and the average life expectancy for extensivestage without treatment is 2 to 4 months and 6 to 12 months with treatment. Asa result, this workshop will focus on new lung cancer prevention and treatmentstrategies.

Session on Breast Cancer

Breastcancer is the most common invasive cancer in women, and it is also thesecond greatest cause of cancer death in women. As you become older, yourchances of developing carcinoma increase. The chance of having cancer in thenext decade is 0.06 per cent at twenty years. By the age of seventy, thepercentage had risen to 3.84 per cent. As a result, this session can focus on enhancingsurvivability.

Sessionon Metastasis and DrugResistance

Cancer cells break awayfrom their original site of formation, migrate via the blood or lymph system,and establish new tumors in distant parts of the body during metastasis.Due to drug resistance, chemotherapyfails to treat the majority of cancer patients with advanced disease,particularly those with the most common kinds of solid tumours. As a result,this session focuses on metastasisrestriction and breakage of drugresistance to treat cancer.

Sessionon Drug Development in Oncology

In 2018, the US Foodand Drug Administration (FDA) approved or added additional indications to47 oncology medications or biologics, while the FDA has already approved 20oncology drugs or biologics in 2019. The drug-development process, which couldlead to approval, is lengthy and involves numerous procedures to guarantee thatthe medication is both safe and effective. We will make a greater contributionto the advancement of this session.

Sessionon Oncology: Lifestyleand Nutrition

Not only for cancertreatment, but for everyone's health, a healthy lifestyle and proper diet areessential. The degree of cancer risk is determined by one's lifestyleand nutrition choices. As a result, this class focuses on how to live ahealthy lifestyle!

Session on ClinicalTrials in Oncology

Even though there are clinical,medicinal,and surgicalways for properly treating cancer patients, many new clinical trials are beingconducted in the development of novel therapeutic approaches to treat cancermore effectively and efficiently. As a result, innovative cancer treatmentprocedures can be brought to the world's attention through this session.

Session on Oncology Nursing & Palliative Care

Palliativecare is a type of patient-centred, family-centered care that aims toimprove quality of life by reducing suffering. Medical specialty nurses have theskills necessary to provide high-quality care, and they are well-positioned tohelp reshape palliative care for cancer patients.

Sessionon Oncology CaseReports

The investigation ofcancer and tumors, such as bar, identification, and treatment information, isreferred to as oncologyand cancer case reports. This case reports aid in the gathering of informationabout diseases and the development of remedies as a result.

Session on Cancerstruggles during COVID-19

People who have had cancertreatment are more likely to have severe COVID-19 disease.Chemotherapy, radiation, and the medications they were given during treatmentmay have weakened their immune systems, making them more susceptible to the corona virus.

Market Analysis

EUROPE: Cancer accounts for 20% of deaths within the European Region.
Europe has around one-quarter of the worldwide total of cancer cases with some 3.7 million new patients p.a.

USA: In 2016, there have been associate calculable 15.5 million cancer survivors within the U.S. The quantity of cancer survivors is predicted to extend to 20.3 million by 2026.
Estimated national expenditures for cancer care within the U.S in 2017 were $147.3 billion.
The most recent Cancer Statistics Review, free in Apr 2018, shows that cancer death rates in USA is minimized by:

1.8% p.a. among men from 2006 to 2015.

1.4% p.a. among girls from 2006 to 2015.

1.4% p.a. among youngsters ages 0–19 from 2011 to 2015

ASIA: Asia has nearly half of cancer incidence rate of North America (152.2 cases/100,000 person-years versus 315.6 cases/100,000 person-years). However, the quantitative relation of cancer deaths to the amount of recent cancer cases in 2012 was higher in Asia (0.66) than in North America (0.33). Republic of India alone accounts for twenty seventh of world cervical cancer deaths, which can flow from to the inconvenience of screening.

Smoking and Tobacco: Smoking, the main explanation for carcinoma, contributes to 80% and 90% of carcinoma deaths in girls and men, severally. Men who smoke are 23 times likely to develop carcinoma. Girls are thirteen times likely to develop, compared to ne'er smokers. In Europe, smoking causes nearly 82% of respiratory organ cancers.

Diet and Physical Activity: Several studies have checked out the chance that specific dietary parts or nutrients either will increase or decreases in cancer risk. Studies of cancer cells within the laboratory and of animal models have typically provided proof that isolated compounds could also be carcinogenic (or have malignant tumour activity). Aiming to stay at a healthy weight is vital to cut back the danger of cancer. To cut back cancer risk, the general public ought is to keep their BMIs below twenty-five. Besides, some of the most important things you can do to help reduce your cancer risk are:

Stay at a healthy weight throughout life.

Be physically active on a daily basis.

Make healthy food decisions with a spot light on plant-based foods.

Sun and Other Types of Radiation: Radiation can cause cancer in most parts of the body and at any age, although radiation-induced solid tumours usually take 10–15 years, and can take up to 40 years, to become clinically manifest, and radiation-induced leukaemia typically require 2–10 years to appear.

Viruses and Other Infections: In the fast developing world, infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus (HIV) accounts for 15% of cancer.

Oncology Associations:

American Society of Clinical Oncology - ASCO

Community Oncology Alliance - COA

Society of Surgical Oncology - SSO

American Society of Therapeutic Radiology and Oncology - ASTRO

American Society of Blood and Marrow Transplantation - ASBMT

American Society of Haematology- ASH

American Association of Cancer Research - AACR

American Cancer Society- ACI

National Cancer Institute- NCI

National Comprehensive Cancer Network- NCCN

Speciality Organisations:

The Society of Gynaecologic Oncology

American Society of Breast Surgeons

Society for Haematology and Stem Cells

The Connective Tissue Oncology Society

Musculoskeletal Tumour Society

American Head and Neck Society

Society for Melanoma Research

Kidney Cancer Association

Society of Urologic Oncology

Society of Interventional Radiology

Association for Cancer Surgery

Pediatric Radiation Oncology Society

American College of Radiation Oncology

Children’s Oncology Group

Society for Integrative Oncology

American Academy of Hospice and Palliative Medicine

Society for Immunotherapy of Cancer

American Psychosocial Oncology Society

American Society of Preventive Oncology

Drug and Pharma – Analysis:

The market for oncology medication is booming, aiding the pharmaceutical trade growth. The oncology drug market is calculable to be nearly ninety four billion USD. Most of the highest pharmaceutical firms are either presently manufacture medicinal drugs or have oncology medications in their R&D pipelines.

Oncology Pharmaceutical Companies

Roche

Bristol – Myers Squibb

Novartis

Pfizer

Celgene

Johnson & Johnson

Astra Zeneca

Abbvie

Lilly

Merck

Past Conference Report

We would like to express a great appreciation to all the plenary speakers and participants joined this international network and visited London, to make their deposit by their high quality presentations, exciting and interesting discussions at the unique atmosphere of this fruitful scientific gathering.

AAC hosted 14th Global Summit on Oncology and Cancer during March 18-19, 2019 at London, UK based on the theme “Ray of Hope on Bridging Cancer Research and Treatment”.

Oncology 2019 was marked with multiple sessions, keynote presentations and panel discussions. We received copious involvement and response from young and brilliant researchers, business delegates and talented communities who made this Conference as one of the most successful and productive events in 2019 from AAC.

The meeting was carried out through different sessions, in which the discussions were held on the following major scientific topics:

Cancer Biology and Oncology

Oncology Causes and Diagnosis

Oncology and Stem cell Treatment

Medical and Radiation Oncology

Cell and Gene Therapy

Immunotherapy and Immuno-oncology

Carcinogenesis and Cancer Mutagenesis

Gynaecologic Oncology

Lung Cancer

Breast Cancer

Conference carried out by various scientific-sessions and plenary lectures in which the following Speakers were highlighted as Keynote speakers:

Stanley P L Leong | California Pacific Medical Center and Research Institute | USA

Raghu Pandurangi | Sci-Engi-Medco Solutions | USA

Stefan Glueck | Celgene Corporation | USA

Raghavan Rajagopalan | Daya Drug Discoveries | USA

Claude Prigent | Université de Rennes | France

Jan Jacques Michiels | Goodheart Institute | The Netherlands

Elena Drozdova | Samara State Medical University | Russia

Kazuko Tatsumura | Gaia Holistic Health | USA

Bhakos A Tannous | Massachusetts General Hospital | USA

George E Chen | The Chinese University of Hong Kong | China

George Vasmatzis | Mayo Clinic | USA

AAC has taken the privilege of felicitating the Organizing Committee, Keynote Speakers and all the speakers who supported for the grand success of this event. We would like to congratulate the awardees for their outstanding performance in the field of Oncology and Cancer and express our gratitude to all the attendees who put their efforts in presentations and sincerely wishes them success in future endeavours.

Following the success of the Oncology 2019 Conference, we are excited to announce the commencement of the 15th Global Summit on Oncology and Cancer.

Bookmark your dates: We hope to see you at Oncology 2022 in London, UK during March 18-19, 2022

PROCEEDING OF ONCOLOGY CONFERENCES

Oncology 2019 Proceedings at https://www.alliedacademies.org/conference-abstracts/oncology-cancer-therapy-2019-proceedings.html

Organizing committee members

Stefan Glueck, PhD

Vice President, Global Medical Affairs

USA

J Michiels, PhD

Founder, BloodCoagulation and Vascular Medicine

Goodheart Institute, The Netherlands

David H Nguyen

Chair, Environmental and Medical Fallout Task Force, Computational Biology

Stanford University School of Medicine, USA

Renowned Speakers

Dimitrios H. Roukos, PhD

Founding Director, Centre for BioSystems and Genome Network Medicine

Ioannina University, Greece

To Collaborate Scientific Professionals around the World

Conference Date	August 01-02, 2022
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Testimonials

Dr Shamsul Islam

QE II Jubilee Hospital, Kesdsels Roaf, Coopers Plains, Brisbane, Australia

I attended the gastroenterology conference and was blown away by the quality of the speakers and the depth of knowledge shared. As a practicing gastroenterologist, I learned new insights and techniques that I can apply in my practice immediately.<

Prof Higinio Mappala

Tower 1 Avida Towers-San Lazaro, F. Huertas St. Sta. Cruz, Manila, Philippines 1003

The gastroenterology conference was a fantastic opportunity to learn about the latest research and treatments in the field. The speakers were engaging, and the sessions were well-structured and informative. I especially appreciated the opportunity